Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2009 Nov 1;100(6):426–431. [Article in French] doi: 10.1007/BF03404338

STOPP-START: Adaptation en langue française d’un outil de détection de la prescription médicamenteuse inappropriée chez la personne âgée

Pierre-Olivier Lang 19,29,✉, Yasmine Hasso 39, Joël Belmin 49, Isabelle Payot 59, Jean-Pierre Baeyens 69, Nicole Vogt-Ferrier 79, Paul Gallagher 89, Denis O’Mahony 89, Jean-Pierre Michel 19
PMCID: PMC6973594  PMID: 20209735

Abstract

Objective

STOPP-START is a screening tool for detecting inappropriate prescriptions in older people. Recently validated in its English-language version, it is a reliable and easy-to-use tool, allowing assessment of prescription drugs often described as inappropriate (STOPP) or unnecessarily underused (START) in this population. An adaptation of the tool into French language is presented here.

Method

A translation-back translation method, with validation of the obtained version by French-speaking experts from Belgium, Canada, France and Switzerland, has been used. An inter-rater reliability analysis completed the validation process. Fifty data sets of patients hospitalized in an academic geriatrics department (mean age ± standard deviation: 77.6 ± 7.9 years; 70% were women) were analyzed independently by one geriatrician and one general practitioner.

Results

The adaptation in French considers the 87 STOPP-START criteria of the original version. They are all organized according to physiological systems. The 50 data sets involved 418 prescribed medications (median 8; inter-quartile range 5–12). The proportions of positive and negative inter-observer agreements were 99% and 95% respectively for STOPP, and 99% and 88% for START; Cohen’s к-coefficients were 0.95 for STOPP and 0.92 for START. These results indicated an excellent inter-rater agreement.

Conclusion

Therefore, this French language version of STOPP-START is as reliable as the original English language version of the tool. For STOPPSTART to have tangible clinical benefit to patients, a randomized controlled trial must be undertaken to demonstrate efficacy in the prevention of adverse clinical events connected with inappropriate prescriptions.

Key words: STOPP START, inappropriate prescription, omission of prescription, adverse drugs event, screening tool, elderly

Références

  • 1.O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: Need for new criteria. Age and Ageing. 2008;37:138–41. doi: 10.1093/ageing/afm189. [DOI] [PubMed] [Google Scholar]
  • 2.Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C e coll. Appropriate prescribing in elderly people: How well can it be measured and optimised? Lancet. 2007;370:173–84. doi: 10.1016/S0140-6736(07)61091-5. [DOI] [PubMed] [Google Scholar]
  • 3.Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalised patients: A meta-analysis of prospective studies. JAMA. 1998;279:1200–5. doi: 10.1001/jama.279.15.1200. [DOI] [PubMed] [Google Scholar]
  • 4.Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: A population-based study of the very old. Drugs Aging. 2005;22:69–82. doi: 10.2165/00002512-200522010-00005. [DOI] [PubMed] [Google Scholar]
  • 5.Laroche ML, Bouthier F, Merle L, Charmes JP. Médicaments potentiellement inappropriés aux personnes âgées: intérêt d’une liste adaptée à la pratique médicale française. Rev Med Int. 2009;30:592–601. doi: 10.1016/j.revmed.2008.08.010. [DOI] [PubMed] [Google Scholar]
  • 6.Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825–32. doi: 10.1001/archinte.1991.00400090107019. [DOI] [PubMed] [Google Scholar]
  • 7.Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7:103–7. [PubMed] [Google Scholar]
  • 8.Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis I e coll. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51. doi: 10.1016/0895-4356(92)90144-C. [DOI] [PubMed] [Google Scholar]
  • 9.Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24. doi: 10.1001/archinte.163.22.2716. [DOI] [PubMed] [Google Scholar]
  • 10.Laroche ML, Charmes JP, Merles L. Potentially inappropriate medications in the elderly: A french consensus panel list. Eur J Clin Pharmacol. 2007;63:725–31. doi: 10.1007/s00228-007-0324-2. [DOI] [PubMed] [Google Scholar]
  • 11.Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83. doi: 10.5414/CPP46072. [DOI] [PubMed] [Google Scholar]
  • 12.Perneger TV, Leplège A, Etter JF. Cross-cultural adaptation of a psychometric instrument: Two methods compared. J Clin Epidemiol. 1999;52:1037–46. doi: 10.1016/S0895-4356(99)00088-8. [DOI] [PubMed] [Google Scholar]
  • 13.Cockcroft DW, Gault MH. Prediction of creatinin clearance from serum creatinin. Nephron. 1976;16:31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  • 14.Katz S. Assessing self-maintenance. Activities of daily-living, mobility and instrumental activities of daily-living. J Am Geriatr Soc. 1983;31:721–27. doi: 10.1111/j.1532-5415.1983.tb03391.x. [DOI] [PubMed] [Google Scholar]
  • 15.Fillenbaum GC. Functional ability. In: Ebrahim S, Kalache A, editors. Epidemiology in Old Age. London: BMJ Publishing Group; 1996. pp. 228–35. [Google Scholar]
  • 16.Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Oxford, UK: Blackwell Scientific; 2002. [Google Scholar]
  • 17.Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46. doi: 10.1177/001316446002000104. [DOI] [Google Scholar]
  • 18.Landis JR, Kock GG. The measurement of observer agreement for categorical data. Biometrics. 1997;33:159–74. doi: 10.2307/2529310. [DOI] [PubMed] [Google Scholar]
  • 19.Cicchetti DV, Feinstein AR. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol. 1990;43:551–58. doi: 10.1016/0895-4356(90)90159-M. [DOI] [PubMed] [Google Scholar]
  • 20.AFSAPS Agence française de sécurité sanitaire des produits de santé. Traitement de l’ostéoporose post-ménopausique. 2006. [Google Scholar]
  • 21.Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B e coll. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing. 2009;38:603–6. doi: 10.1093/ageing/afp058. [DOI] [PubMed] [Google Scholar]
  • 22.Nelson EA, Dannefer D. Aged heterogeneity: Fact or fiction? The fate of diversity in gerontological research. Gerontologist. 1992;32:17–23. doi: 10.1093/geront/32.1.17. [DOI] [PubMed] [Google Scholar]
  • 23.Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA. 2005;294:716–24. doi: 10.1001/jama.294.6.716. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES